The development of a project for a new
pharmaceutical manufacturing plant with our
consultants will allow you having a plant with an
appropriate design to fulfill GMP requirements and
minimise risks of contamination as well as meeting
the current qualification and validation standards.
About this Case Study
An international pharmaceutical company in Portugal expanded its operations with a new solid dosage form plant to serve the EU and US markets. The project involved establishing a Validation Master Plan, reviewing GMP compliance, and implementing qualification protocols for equipment, utilities, and cleaning methods. The facility was designed to minimise contamination risks and ensure GMP compliance, meeting both local and international regulatory standards.
Discover how our consultants helped streamline the process and ensure seamless project delivery—read more to see how we supported the client in achieving their goals.
Download the Case Study
View other our other resources and company news
CSV Practical Guide to the EMA’s Draft EU GMP Revisions
Guide Practical Guide to Post-Market Surveillance (PMS) under EU MDR/IVDR
Blog AI for Pharmaceutical SOPs: Transforming Quality Management and Compliance
CAPA Strengthening CAPA & Exceptions Management
Blog EU GMP Annex 1 vs FDA Aseptic Guide: Bridging Compliance
Blog GMP & GDP: Ensuring Quality in Drug Storage and Transport
Blog Blockchain for GMP Documentation: Hype or Future Reality?
Guide Is Your Insurance Policy Ready for the New EU Product Liability Directive?
Article 